Charles River Laboratories News and Resources

Charles River Laboratories, a provider of products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics, has announced a high-quality (HQ) plasmid DNA development and manufacturing agreement with the National University of

Charles River Laboratories, a cell therapy contract development and manufacturing organisation (CDMO), has announced a new partnership with Navega Therapeutics. The collaboration is centred on the production of an adeno-associated virus 9 (AAV9) candidate, NT-Z001, a non-opioid alternative for patients living